FibroBiologics FBLG
NASDAQ FBLG
$1.00 +0.07 (+7.78%)
At close: Nov 11, 2026 · 4:00 PM EST

FibroBiologics (FBLG) Short term Debt (2024 - 2026)

Updated

FibroBiologics' Short term Debt came in at $124,000 for Q2 2026, down 49.6% from the prior quarter.

Analysis

FibroBiologics (FBLG) Short term Debt (2024 - 2026) Analysis & Trends

Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Eli Lilly 1,348.13 Bn 1,321.74 Bn 20.46 Bn
2 Johnson & Johnson 675.90 Bn 595.76 Bn 17.30 Bn
3 AbbVie 519.45 Bn 487.50 Bn 13.12 Bn
4 Merck 364.95 Bn 327.95 Bn 13.19 Bn
5 Novartis Ag 311.58 Bn 285.16 Bn -
6 Astrazeneca 289.34 Bn 262.94 Bn 13.26 Bn
7 Amgen 251.64 Bn 203.30 Bn 7.58 Bn
8 Gilead Sciences 212.05 Bn 187.07 Bn 6.73 Bn
9 Pfizer 167.35 Bn 115.00 Bn 12.56 Bn
10 FibroBiologics 6.13 Mn -8.69 Mn -
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 124,000.00
Mar 31, 2026 246,000.00
Sep 30, 2025 4.57 Mn
Dec 31, 2024 9.17 Mn
API Access

FibroBiologics Short term Debt API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=short-term-debt&ticker=FBLG&period=max&api_key=YOUR_API_KEY